tiprankstipranks
Trending News
More News >
Poolbeg Pharma Ltd. (GB:POLB)
LSE:POLB
UK Market

Poolbeg Pharma Ltd. (POLB) Income Statement

Compare
26 Followers

Poolbeg Pharma Ltd. Income Statement

Last quarter (Q2 2025), Poolbeg Pharma Ltd.'s total revenue was £0.00, a decrease of ― from the same quarter last year. In Q2, Poolbeg Pharma Ltd.'s net income was £-2.18M. See Poolbeg Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit
£ -114.00K£ -26.00K£ -26.00K£ -18.00K
Operating Expenses
£ 6.37M£ 5.04M£ 4.99M£ 2.36M
Depreciation and Amortization
£ 114.00K£ 26.00K£ 26.00K£ 18.00K
EBITDA
£ -6.00M£ -4.66M£ -4.75M£ -2.32M
Operating Income
£ -6.62M£ -5.04M£ -4.99M£ -2.38M
Other Income/Expenses
£ 674.00K£ 534.00K£ 209.00K£ 42.00K
Pretax Income
£ -5.94M£ -4.50M£ -4.78M£ -2.34M
Net Income
£ -5.79M£ -3.93M£ -4.69M£ -2.34M
Per Share Metrics
Basic EPS
£ -0.01£ -7.90£ -9.37£ -4.67
Diluted EPS
£ -0.01£ -7.86£ -9.37£ -4.67
Weighted Average Shares Outstanding
499.14M 497.59K 500.00K 500.00K
Weighted Average Shares Outstanding (Diluted)
500.00M 500.00K 500.00K 500.00K
Currency in GBP

Poolbeg Pharma Ltd. Earnings and Revenue History